查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球生长因子市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按产品、按等级、按应用、按最终用户、按地区
市场调查报告书
商品编码
1394153

全球生长因子市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按产品、按等级、按应用、按最终用户、按地区

Growth Factors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 391 Pages | 商品交期: 2-5个工作天内

价格
简介目录

全球生长因子市场规模预计将大幅扩大，从 2024 年的 22 亿美元增至 2031 年底的 38 亿美元。 製造商在推动这一增长、彻底改变皮肤再生、伤口癒合和治疗应用方面发挥关键作用。

生长因子已成为皮肤再生和伤口癒合的基石。 研究人员正在努力开发超越单一生长因子解决方案的开创性产品，为市场的重大成长机会铺路。 此外，亚太地区的快速成长以及专门生产良好生产规范 (GMP) 级产品的公司数量有限，为生长因子製造商提供了巨大的潜力。

细胞激素和生长因子在治疗各种疾病方面的治疗潜力预计将推动市场扩张。 自体免疫疾病和癌症盛行率的上升将进一步推动这一成长轨迹。

业界领先的进入者策略性地专注于新产品的批准、发布、研究合作、协议和伙伴关係。 这些策略旨在加强我们的产品组合併扩大我们的区域业务。 併购以及研发投资也是在各个治疗和科学领域中利用成长因素的关键策略。

然而，生长因子市场面临的挑战主要是由于成本高和缺乏熟练的专业人员。 某些生长因子的成本阻碍了它们在实验室中的采用。 合格专业人员的稀缺性以及获得必要设备和配件的机会有限，进一步阻碍了市场的扩张。

本报告调查了全球生长因子市场，并提供了市场概述，以及按产品、等级、应用、最终用户、区域划分的趋势以及进入市场的公司的竞争趋势。

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 乌克兰和俄罗斯之间衝突的影响
  • 经济概况
  • 杵分析

第 3 章 2018-2031 年全球生长因子市场展望

  • 2018-2031 年全球成长因素市场前景（依产品、价值、数量划分）
  • 2018-2031 年全球生长因子市场前景（依等级、价值、数量划分）
  • 2018-2031 年全球生长因子市场前景（按应用、金额、数量划分）
  • 2018-2031 年全球生长因子市场展望（依最终使用者、价值、数量）
  • 2018-2031 年全球生长因子市场前景（按地区、价值、数量划分）

第 4 章北美生长因子市场展望，2018-2031

第 5 章欧洲生长因子市场展望，2018-2031

第 6 章亚太地区生长因子市场展望，2018-2031

第 7 章拉丁美洲生长因子市场展望，2018-2031

第 8 章中东与非洲生长因子市场展望，2018-2031 年

第九章竞争态势

  • 依用途和等级划分的热图
  • 按製造商和等级划分的热图
  • 2023 年公司市占率分析
  • 竞争力仪表板
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Lonza Group AG
    • Merck KGaA
    • General Electronics Company
    • F. Hoffmann-La Roche Ltd
    • Applied Biological Materials (abm), Inc
    • Abcam plc.
    • Cell Signaling Technology, Inc.
    • Sartorius CellGenix GmbH
    • Bio-Techne
    • Proteintech Group, Inc
    • Miltenyi Biotec
    • Creative Bioarray
    • Akron Biotech
    • Sino Biological Inc.
    • Repligen corporation
    • LEADGENE BIOMEDICAL, INC.
    • PeproTech In

第 10 章附录

简介目录

The global growth factors market is poised for substantial expansion, with a remarkable surge in revenue from US $2.2 billion in 2024 to an estimated US $3.8 billion by the end of 2031. Manufacturers are playing a pivotal role in propelling this growth, revolutionizing skin regeneration, wound healing, and therapeutic applications.

Manufacturers Spearhead Market Growth

Growth factors have emerged as a cornerstone for skin regeneration and wound healing. Researchers are diligently working on pioneering products that extend beyond single growth factor solutions, paving the way for significant opportunities in the market. Additionally, the rapid growth of the Asia Pacific region and a limited number of companies specializing in Good Manufacturing Practice (GMP)-grade products create vast prospects for growth factor manufacturers.

Cytokine and Growth Factors Therapy Expands

The therapeutic potential of cytokine and growth factors in treating a range of disorders is expected to bolster market expansion. The rising prevalence of autoimmune diseases and cancer further fuels this growth trajectory.

Key Players Drive Expansion

Leading industry players are strategically focusing on new product approvals, launches, collaborations, agreements, and partnerships. These tactics are aimed at strengthening product portfolios and expanding regional presence. Mergers and acquisitions, along with investments in research and development, are also key strategies to harness growth factors in various therapeutic and scientific domains.

Challenges Ahead

However, the growth factors market faces its share of challenges, primarily stemming from high costs and a shortage of skilled professionals. The cost of certain growth factors hampers their adoption in research laboratories. A dearth of qualified experts and limited access to necessary equipment and accessories further impede market expansion.

Country-wise Insights

Why the U.S. is Thriving

The United States is witnessing a burgeoning demand for growth factors, driven by government initiatives supporting research activities and the growing importance of growth factors and cytokines in stem cell biology.

China's Emergence

China has become a prominent market for growth factors, particularly in the wake of the COVID-19 pandemic. As larger Chinese companies focus on developing growth factor-based medicines to combat the virus, the market for these products is rapidly expanding throughout China and East Asia.

Germany's Appeal

Germany stands out as a lucrative market for growth factors in Europe due to rising healthcare spending and the presence of robust manufacturing facilities. Major companies are expanding their product offerings through strategic acquisitions, such as Sartorius AG's acquisition of CellGenix in 2021 to bolster its cell and gene therapy product line.

Competitive Landscape

Key players in the growth factors market, including Thermo Fisher Scientific, Lonza Group AG, Merck KGaA, and others, are actively pursuing strategies to enhance their global presence. These strategies encompass new product releases, business expansion, approvals, partnerships, agreements, collaborations, and diversified distribution channels, including online sales.

Key Companies Profiled:

  • Thermo Fisher Scientific
  • Lonza Group AG
  • Merck KGaA
  • General Electronics Company
  • F. Hoffmann-La Roche Ltd
  • Applied Biological Materials (abm), Inc
  • Abcam plc.
  • Cell Signaling Technology, Inc.
  • Meridian Bioscience Inc.
  • Sartorius CellGenix GmbH
  • Bio-Techne.
  • Proteintech Group, Inc.
  • Miltenyi Biotec
  • Creative Bioarray
  • Akron Biotech
  • Sino Biological Inc.
  • Repligen Corporation
  • LEADGENE BIOMEDICAL, INC.
  • PeproTech Inc.

Key Segments of the Growth Factors Industry Research:

By Product:

  • Transforming Growth Factors (TGF)

Activin

  • Bone Morphogenetic Proteins (BMPs)

TGF-beta Proteins

  • Epidermal Growth Factors (EGFs)
  • Platelet-Derived Growth Factors (PDGFs)
  • Fibroblast Growth Factors (FGFs)
  • Insulin-like Growth Factors (IGFs)
  • Vascular Endothelial Growth Factors (VEGFs)
  • Hepatocyte Growth Factors (HGFs)
  • Tumour Necrosis Factors (TNFs)
  • Interleukins
  • Others

By Grade:

  • GMP Grade
  • NON-GMP Grade

By Application:

  • Oncology Research
  • Hematology Research
  • Wound Healing Research
  • Dermatology Research
  • Cardiovascular Disease & Diabetes
  • Cell therapy and Ex vivo manufacturing
  • Others

By End User:

  • Pharmaceutical and Biotechnology Companies
  • Research Centres & Academic Institutes
  • CMO and CDMO

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Growth Factors Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Growth Factors Market Outlook, 2018 - 2031

  • 3.1. Global Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Transforming Growth Factors (TGF)
        • 3.1.1.1.1. Activin
        • 3.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
        • 3.1.1.1.3. TGF-beta Proteins
      • 3.1.1.2. Epidermal Growth Factors (EGFs)
      • 3.1.1.3. Platelet-Derived Growth Factors (PDGFs)
      • 3.1.1.4. Fibroblast Growth Factors (FGFs)
      • 3.1.1.5. Insulin-like Growth Factors (IGFs)
      • 3.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
      • 3.1.1.7. Hepatocyte Growth Factors (HGFs)
      • 3.1.1.8. Tumour Necrosis Factors (TNFs)
      • 3.1.1.9. Interleukins
      • 3.1.1.10. Others
  • 3.2. Global Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. GMP Grade
      • 3.2.1.2. NON-GMP Grade
  • 3.3. Global Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Oncology Research
      • 3.3.1.2. Hematology Research
      • 3.3.1.3. Wound Healing Research
      • 3.3.1.4. Dermatology Research
      • 3.3.1.5. Cardiovascular Disease & Diabetes
      • 3.3.1.6. Cell therapy and Ex vivo manufacturing
      • 3.3.1.7. Others
  • 3.4. Global Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Pharmaceutical and Biotechnology Companies
      • 3.4.1.2. Research Centres & Academic Institutes
      • 3.4.1.3. CMO and CDMO
  • 3.5. Global Growth Factors Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Growth Factors Market Outlook, 2018 - 2031

  • 4.1. North America Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Transforming Growth Factors (TGF)
        • 4.1.1.1.1. Activin
        • 4.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
        • 4.1.1.1.3. TGF-beta Proteins
      • 4.1.1.2. Epidermal Growth Factors (EGFs)
      • 4.1.1.3. Platelet-Derived Growth Factors (PDGFs)
      • 4.1.1.4. Fibroblast Growth Factors (FGFs)
      • 4.1.1.5. Insulin-like Growth Factors (IGFs)
      • 4.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
      • 4.1.1.7. Hepatocyte Growth Factors (HGFs)
      • 4.1.1.8. Tumour Necrosis Factors (TNFs)
      • 4.1.1.9. Interleukins
      • 4.1.1.10. Others
  • 4.2. North America Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. GMP Grade
      • 4.2.1.2. NON-GMP Grade
  • 4.3. North America Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Oncology Research
      • 4.3.1.2. Hematology Research
      • 4.3.1.3. Wound Healing Research
      • 4.3.1.4. Dermatology Research
      • 4.3.1.5. Cardiovascular Disease & Diabetes
      • 4.3.1.6. Cell therapy and Ex vivo manufacturing
      • 4.3.1.7. Others
  • 4.4. North America Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Pharmaceutical and Biotechnology Companies
      • 4.4.1.2. Research Centres & Academic Institutes
      • 4.4.1.3. CMO and CDMO
  • 4.5. North America Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.2. U.S. Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.3. U.S. Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.4. U.S. Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.5. Canada Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.6. Canada Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.7. Canada Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.8. Canada Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Growth Factors Market Outlook, 2018 - 2031

  • 5.1. Europe Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Transforming Growth Factors (TGF)
        • 5.1.1.1.1. Activin
        • 5.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
        • 5.1.1.1.3. TGF-beta Proteins
      • 5.1.1.2. Epidermal Growth Factors (EGFs)
      • 5.1.1.3. Platelet-Derived Growth Factors (PDGFs)
      • 5.1.1.4. Fibroblast Growth Factors (FGFs)
      • 5.1.1.5. Insulin-like Growth Factors (IGFs)
      • 5.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
      • 5.1.1.7. Hepatocyte Growth Factors (HGFs)
      • 5.1.1.8. Tumour Necrosis Factors (TNFs)
      • 5.1.1.9. Interleukins
      • 5.1.1.10. Others
  • 5.2. Europe Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. GMP Grade
      • 5.2.1.2. NON-GMP Grade
  • 5.3. Europe Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Oncology Research
      • 5.3.1.2. Hematology Research
      • 5.3.1.3. Wound Healing Research
      • 5.3.1.4. Dermatology Research
      • 5.3.1.5. Cardiovascular Disease & Diabetes
      • 5.3.1.6. Cell therapy and Ex vivo manufacturing
      • 5.3.1.7. Others
  • 5.4. Europe Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Pharmaceutical and Biotechnology Companies
      • 5.4.1.2. Research Centres & Academic Institutes
      • 5.4.1.3. CMO and CDMO
  • 5.5. Europe Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.2. Germany Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.3. Germany Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.4. Germany Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.5. U.K. Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.6. U.K. Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.7. U.K. Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.8. U.K. Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.9. France Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.10. France Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.11. France Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.12. France Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.13. Italy Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.14. Italy Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.15. Italy Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.16. Italy Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.17. Turkey Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.18. Turkey Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.19. Turkey Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.20. Turkey Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.21. Russia Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.22. Russia Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.23. Russia Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.24. Russia Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.25. Rest of Europe Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.26. Rest of Europe Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.27. Rest of Europe Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.28. Rest of Europe Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Growth Factors Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Transforming Growth Factors (TGF)
        • 6.1.1.1.1. Activin
        • 6.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
        • 6.1.1.1.3. TGF-beta Proteins
      • 6.1.1.2. Epidermal Growth Factors (EGFs)
      • 6.1.1.3. Platelet-Derived Growth Factors (PDGFs)
      • 6.1.1.4. Fibroblast Growth Factors (FGFs)
      • 6.1.1.5. Insulin-like Growth Factors (IGFs)
      • 6.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
      • 6.1.1.7. Hepatocyte Growth Factors (HGFs)
      • 6.1.1.8. Tumour Necrosis Factors (TNFs)
      • 6.1.1.9. Interleukins
      • 6.1.1.10. Others
  • 6.2. Asia Pacific Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. GMP Grade
      • 6.2.1.2. NON-GMP Grade
  • 6.3. Asia Pacific Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Oncology Research
      • 6.3.1.2. Hematology Research
      • 6.3.1.3. Wound Healing Research
      • 6.3.1.4. Dermatology Research
      • 6.3.1.5. Cardiovascular Disease & Diabetes
      • 6.3.1.6. Cell therapy and Ex vivo manufacturing
      • 6.3.1.7. Others
  • 6.4. Asia Pacific Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Pharmaceutical and Biotechnology Companies
      • 6.4.1.2. Research Centres & Academic Institutes
      • 6.4.1.3. CMO and CDMO
  • 6.5. Asia Pacific Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.2. China Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.3. China Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.4. China Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.5. Japan Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.6. Japan Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.7. Japan Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.8. Japan Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.9. South Korea Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.10. South Korea Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.11. South Korea Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.12. South Korea Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.13. India Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.14. India Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.15. India Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.16. India Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.17. Southeast Asia Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.18. Southeast Asia Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.19. Southeast Asia Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.20. Southeast Asia Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Growth Factors Market Outlook, 2018 - 2031

  • 7.1. Latin America Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Transforming Growth Factors (TGF)
        • 7.1.1.1.1. Activin
        • 7.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
        • 7.1.1.1.3. TGF-beta Proteins
      • 7.1.1.2. Epidermal Growth Factors (EGFs)
      • 7.1.1.3. Platelet-Derived Growth Factors (PDGFs)
      • 7.1.1.4. Fibroblast Growth Factors (FGFs)
      • 7.1.1.5. Insulin-like Growth Factors (IGFs)
      • 7.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
      • 7.1.1.7. Hepatocyte Growth Factors (HGFs)
      • 7.1.1.8. Tumour Necrosis Factors (TNFs)
      • 7.1.1.9. Interleukins
      • 7.1.1.10. Others
  • 7.2. Latin America Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.2.1.1. GMP Grade
      • 7.2.1.2. NON-GMP Grade
  • 7.3. Latin America Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Oncology Research
      • 7.3.1.2. Hematology Research
      • 7.3.1.3. Wound Healing Research
      • 7.3.1.4. Dermatology Research
      • 7.3.1.5. Cardiovascular Disease & Diabetes
      • 7.3.1.6. Cell therapy and Ex vivo manufacturing
      • 7.3.1.7. Others
  • 7.4. Latin America Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Pharmaceutical and Biotechnology Companies
      • 7.4.1.2. Research Centres & Academic Institutes
      • 7.4.1.3. CMO and CDMO
  • 7.5. Latin America Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.2. Brazil Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.3. Brazil Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.4. Brazil Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.5. Mexico Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.6. Mexico Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.7. Mexico Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.8. Mexico Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.9. Argentina Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.10. Argentina Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.11. Argentina Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.12. Argentina Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Growth Factors Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Transforming Growth Factors (TGF)
        • 8.1.1.1.1. Activin
        • 8.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
        • 8.1.1.1.3. TGF-beta Proteins
      • 8.1.1.2. Epidermal Growth Factors (EGFs)
      • 8.1.1.3. Platelet-Derived Growth Factors (PDGFs)
      • 8.1.1.4. Fibroblast Growth Factors (FGFs)
      • 8.1.1.5. Insulin-like Growth Factors (IGFs)
      • 8.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
      • 8.1.1.7. Hepatocyte Growth Factors (HGFs)
      • 8.1.1.8. Tumour Necrosis Factors (TNFs)
      • 8.1.1.9. Interleukins
      • 8.1.1.10. Others
  • 8.2. Middle East & Africa Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. GMP Grade
      • 8.2.1.2. NON-GMP Grade
  • 8.3. Middle East & Africa Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Oncology Research
      • 8.3.1.2. Hematology Research
      • 8.3.1.3. Wound Healing Research
      • 8.3.1.4. Dermatology Research
      • 8.3.1.5. Cardiovascular Disease & Diabetes
      • 8.3.1.6. Cell therapy and Ex vivo manufacturing
      • 8.3.1.7. Others
  • 8.4. Middle East & Africa Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Pharmaceutical and Biotechnology Companies
      • 8.4.1.2. Research Centres & Academic Institutes
      • 8.4.1.3. CMO and CDMO
  • 8.5. Middle East & Africa Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.2. GCC Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.3. GCC Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.4. GCC Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.5. South Africa Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.6. South Africa Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.7. South Africa Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.8. South Africa Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.9. Egypt Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.10. Egypt Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.11. Egypt Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.12. Egypt Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.13. Nigeria Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.14. Nigeria Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.15. Nigeria Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.16. Nigeria Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. by Application vs by Grade Heatmap
  • 9.2. Manufacturer vs by Grade Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Thermo Fisher Scientific Inc.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Lonza Group AG
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Merck KGaA
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. General Electronics Company
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. F. Hoffmann-La Roche Ltd
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Applied Biological Materials (abm), Inc
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Abcam plc.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Cell Signaling Technology, Inc.
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
      • 9.5.8.5. Meridian Bioscience Inc.
      • 9.5.8.6. Company Overview
      • 9.5.8.7. Product Portfolio
      • 9.5.8.8. Financial Overview
      • 9.5.8.9. Business Strategies and Development
    • 9.5.9. Sartorius CellGenix GmbH
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Bio-Techne
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Proteintech Group, Inc
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Miltenyi Biotec
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. Creative Bioarray
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Akron Biotech
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development
    • 9.5.15. Sino Biological Inc.
      • 9.5.15.1. Company Overview
      • 9.5.15.2. Product Portfolio
      • 9.5.15.3. Financial Overview
      • 9.5.15.4. Business Strategies and Development
    • 9.5.16. Repligen corporation
      • 9.5.16.1. Company Overview
      • 9.5.16.2. Product Portfolio
      • 9.5.16.3. Financial Overview
      • 9.5.16.4. Business Strategies and Development
    • 9.5.17. LEADGENE BIOMEDICAL, INC.
      • 9.5.17.1. Company Overview
      • 9.5.17.2. Product Portfolio
      • 9.5.17.3. Financial Overview
      • 9.5.17.4. Business Strategies and Development
    • 9.5.18. PeproTech In
      • 9.5.18.1. Company Overview
      • 9.5.18.2. Product Portfolio
      • 9.5.18.3. Financial Overview
      • 9.5.18.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations